REGENERON PHARMACEUTICALS, INC. - COM (REGN)

Q4 2024 13F Holders as of 12/31/2024

Type / Class
Equity / COM
Number of holders
471
Total Shares
3.98M
Shares change
+71.9K
Total reported value, excl. options
$2.83B
Value change
+$16.6M
Put/Call ratio
2.2
Number of buys
188
Number of sells
-259
Price
$712.33
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.